ESR1 and breast cancer: Reported experimental data demonstrated that the multifunctional multicolor nanosystems are capable of the selective and simultaneous capture of targeted TNBC, HER-2(+) or ER(+) breast cancer cells, and the capture efficiency can be as high as 98%.